Clinical Trials in Chicago

Showing 7001-7020 of 15,574 trials

A Study of Modified Stem Cells in Stable Ischemic Stroke

NCT01287936

The primary purpose of the clinical study is to determine the safety of a modified stem cell SB623 when administered to chronic, stable ischemic stroke patients. A second purpose is to determine whether SB623 might improve stroke symptoms. Chronic, stable ischemic stroke patients must be between 6 and 60 months after their stroke, and with only this one prior stroke, and with no further improvement from physical therapy.

Chronic Ischemic Stroke

SanBio, Inc.18 participantsStarted Jan 2011

Birmingham, Alabama, United States • Stanford, California, United States • Atlanta, Georgia, United States +2 more locations

WITHDRAWNNA2.2 miles

rTMS for Relieving Chronic OA Pain

NCT05097729

In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with pain due to knee osteoarthritis.

Chronic PainOsteo Arthritis Knee

Northwestern UniversityStarted Nov 2021

Chicago, Illinois, United States

WITHDRAWNPhase 42.2 miles

Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline

NCT01309074

The aim of the study is to compare the safety \& efficacy of sertraline (up to a dose of 200mg/day) \& pregabalin (up to a dose of 300mg/day) for the treatment of symptoms of anxiety in patients with epilepsy.

EpilepsyAnxiety

Rush University Medical CenterStarted Nov 2009

Chicago, Illinois, United States

A Study of Modified Stem Cells in Stable Ischemic Stroke

rTMS for Relieving Chronic OA Pain

Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline

Find Trials by Condition in Chicago

Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Androgen Reduction in Congenital Adrenal Hyperplasia

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment